Loading...
Determination of the Proteomic Response to Lapatinib Treatment using a comprehensive and reproducible ion-current-based proteomics strategy
Lapatinib, a small molecule tyrosine kinase inhibitor is currently used in the treatment of HER2-positive breast cancer. The aim of this study was to further understanding of lapatinib response for the development of novel treatment lapatinib-focussed treatment strategies. HER2-overexpressing SKBR3...
Na minha lista:
| Udgivet i: | J Proteom Genom Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642974/ https://ncbi.nlm.nih.gov/pubmed/29046878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14302/issn.2326-0793.jpgr-13-257 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|